Uri MD - Pardes Biosciences Founder Director
| PRDSDelisted Stock | USD 2.14 0.01 0.47% |
Insider
Uri MD is Founder Director of Pardes Biosciences
| Age | 51 |
| Phone | 415 649 8758 |
| Web | https://www.pardesbio.com |
Pardes Biosciences Management Efficiency
The company has return on total asset (ROA) of (0.2649) % which means that it has lost $0.2649 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4028) %, meaning that it created substantial loss on money invested by shareholders. Pardes Biosciences' management efficiency ratios could be used to measure how well Pardes Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Casi DeYoung | Shattuck Labs | 53 | |
| Shane Williams | Century Therapeutics | N/A | |
| Michael MBA | Champions Oncology | N/A | |
| Sergey Yurasov | Nuvation Bio | 51 | |
| BS CMAR | Champions Oncology | N/A | |
| Robert MBA | Eliem Therapeutics | 56 | |
| Andrew MBA | Shattuck Labs | 38 | |
| Lei Sun | Connect Biopharma Holdings | 60 | |
| Tharaknath Rao | Assembly Biosciences | N/A | |
| David MBA | Champions Oncology | 55 | |
| Zoology Dphil | Ovid Therapeutics | 69 | |
| W Vernon | Nuvation Bio | 65 | |
| Gregory Russotti | Century Therapeutics | 57 | |
| Mark Dudley | Instil Bio | N/A | |
| David Hanley | Nuvation Bio | 54 | |
| Jamie Moore | CytomX Therapeutics | N/A | |
| MPH MD | Connect Biopharma Holdings | 54 | |
| Kim Blickenstaff | Nuvation Bio | 68 | |
| Mark Wallet | Century Therapeutics | N/A | |
| Robert Bazemore | Nuvation Bio | 53 | |
| Conor Richardson | Shattuck Labs | N/A | |
Management Performance
| Return On Equity | -0.4 | |||
| Return On Asset | -0.26 |
Pardes Biosciences Leadership Team
Elected by the shareholders, the Pardes Biosciences' board of directors comprises two types of representatives: Pardes Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pardes. The board's role is to monitor Pardes Biosciences' management team and ensure that shareholders' interests are well served. Pardes Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pardes Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Elizabeth JD, Gen Sec | ||
| Heidi CPA, Chief Officer | ||
| Dave Kuo, VP HR | ||
| Uri MD, Founder Director | ||
| Valdas Jurkauskas, VP Operations | ||
| Thomas Wiggans, CEO Chairman | ||
| Patrick OBrien, VP Relations | ||
| Sean Brusky, Chief Officer | ||
| Brian PharmD, Chief Officer | ||
| Ann Kwong, Ex Research |
Pardes Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Pardes Biosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.4 | |||
| Return On Asset | -0.26 | |||
| Current Valuation | (22.1 M) | |||
| Shares Outstanding | 62.01 M | |||
| Shares Owned By Insiders | 13.47 % | |||
| Shares Owned By Institutions | 72.05 % | |||
| Number Of Shares Shorted | 874.35 K | |||
| Price To Book | 0.37 X | |||
| EBITDA | (99.82 M) | |||
| Net Income | (96.63 M) |
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in Pardes Stock
If you are still planning to invest in Pardes Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pardes Biosciences' history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |